Media Center
Press Releases

Press Releases

26 Aug 15
Life Cycle Management Strategies More Crucial than Ever for Pharmaceutical Success

With shrinking Research and Development (R&D) pipelines and mounting costs involved in drug development, it is becoming increasingly important for pharmaceutical companies to implement suitable Life Cycle Management (LCM) strategies in order to maximize revenues and the lifespan of their portfolios, says business intelligence provider GBI Research.

Read post
20 Aug 15
Global Multiple Myeloma Treatment Market Value to Approach $9 Billion by 2021, says GBI Research

The global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021, representing a moderate Compound Annual Growth Rate (CAGR) of 4.6%.

Read post
04 Aug 15
Oncology Treatment Offers Significant Opportunities with Largest Pipeline in Pharmaceuticals

The oncology drug pipeline is far larger than any other therapy area across the pharmaceutical industry, with 6,484 products in active development across all indications, suggesting significant opportunities for new market entries, according to business intelligence provider GBI Research.

Read post
23 Jul 15
Type 2 Diabetes Mellitus Treatment Market Value Will Reach $39 Billion by 2021, says GBI Research

The global market for Type 2 Diabetes Mellitus (T2DM) therapeutics will rise in value from $23.5 billion in 2014 to an estimated $39 billion by 2021, driven primarily by rising disease prevalence and the continued uptake of recently approved and emerging branded treatments, according to business intelligence provider GBI Research.

Read post
14 Jul 15
Anti-hypertensive Therapeutics Market Value in Asia-Pacific to Approach $20 Billion by 2021

The anti-hypertensive therapeutics market in the Asia-Pacific (APAC) countries of Australia, India, China, and Japan will expand in value from $15.7 billion in 2014 to reach $19.9 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 3.4%, according to business intelligence provider GBI Research.

Read post